A course series to help C/T researchers utilize imaging technology. Advanced Imaging for Clinical/Translational Researchers

Imaging in Clinical/Translational Cancer Research

At a glance
Opportunity for
  • An overview of imaging modalities and their application in clinical/translational cancer research.
Eligibility
Ideal candidates will:
  • have an MD, DMD, PharmD, or PhD, and be poised to begin, or currently be actively engaged in basic or clinical research.
    (See Admissions Requirements for more details.)
Time commitment
  • 3 days
Funding level
  • Tuition-free*
Session dates
  • September 30 - October 2, 2013
Application Due
  • 5:00pm on September 20, 2013
  • Applications and endorsements are due at this time.
Note: The application process is closed. Please check back for future opportunities.

Are you interested in using imaging as a tool to unlock questions in your oncology research? Do you need an overview of the different preclinical and clinical imaging modalities available? Would you like the opportunity to network with imaging experts in the Harvard community? If yes, we invite you to participate in this new and exciting course.

This three-day course offers an overview of the utility of imaging in research in its application to oncology. Participants will have the opportunity to consider how they might use imaging in their own preclinical or clinical research. The specific goals of this course are to:

  • introduce attendees to the available imaging technologies commonly used in cancer research;
  • convey the potential, as well as the limitations of these approaches;
  • expose attendees to a variety of applications of the imaging technologies; and
  • present the types of imaging biomarkers and endpoints that could be used in clinical trials.

The course will consist of didactic lectures and interactive components based on the following topics:

  • Anatomic Imaging and Therapy Guidance
  • Functional/Molecular Imaging
  • Preclinical Imaging
  • Emerging Technologies

Course Schedule [PDF]

Dates and Location

  • September 30-October 2, 2013, 8:00am-5:00pm
  • Sheraton Commander Hotel, Cambridge, MA

Admission Requirements

  • MD, DMD, PharmD, PhD, or equivalent
  • Interest in clinical and translational cancer research
  • Commitment to attend the entire course (three full days)
  • An endorsement from your supervisor stating that you will be able to attend the entire course
  • Be members of (in the order of preferential acceptance):
    • Harvard or a Harvard-affiliated institution
    • a Massachusetts CTSA
    • a national CTSA
    • a national academic institution or regulatory agency
    • a relevant external organization

*Harvard Catalyst's Postgraduate Education Program offers first priority to applicants who are current Harvard students, faculty, or current employees of Harvard University, its ten schools, and its seventeen Academic Healthcare Centers (AHC), or students at Boston College School of Nursing, MIT, or Harvard Pilgrim Health Care. A complete list of participating institutions can be found on the About Harvard Catalyst page. External applicants not affiliated with the National CTSA Consortium are accepted for a fee when space is available. For additional details, please contact the course/program's designated Postgraduate Education Program developer.